drugset / Trial / NCT07360483

Treatment of Hypertrophic Scars Using Fractional CO2 Laser Alone in Comparison With Adding Botulinum Toxin Either Through Intralesional Injection or Assisted Drug Delivery

NCT07360483

Completed 48 enrolled Cairo University
RandomizedParallel-groupSingle-blindTreatment

Summary

The current study aimed to evaluate the effectiveness of fractional laser treatment alone and fractional laser combined with botulinum toxin A, delivered either through injections or topical application fractional laser-assisted drug delivery (FLADD) in hypertrophic burn scar

Timeline

Start
2025-01-01
Primary completion
2025-05-01
Completion
2025-08-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 2.5 iu Other

Indications

No indication recorded.